These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 24080763)

  • 1. Impact of chronic kidney disease in early invasive versus early conservative revascularization strategies in non-ST-segment elevation acute coronary syndromes: a population-based study from NHIRD of Taiwan.
    Chu CY; Su HM; Hsu PC; Lee WH; Lin TH; Voon WC; Lai WT; Sheu SH
    Nephron Clin Pract; 2013; 124(1-2):38-46. PubMed ID: 24080763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of impaired glomerular filtration rate and revascularization strategy on one-year cardiovascular events in acute coronary syndrome: data from Taiwan acute coronary syndrome full spectrum registry.
    Lin TH; Hsin HT; Wang CL; Lai WT; Li AH; Kuo CT; Hwang JJ; Chiang FT; Chang SC; Chang CJ;
    BMC Nephrol; 2014 Apr; 15():66. PubMed ID: 24758190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early versus delayed percutaneous coronary intervention for patients with non-ST segment elevation acute coronary syndrome: a meta-analysis of randomized controlled clinical trials.
    Rajpurohit N; Garg N; Garg R; Choudhary A; Fresen J; Boren S; Dellsperger KC; Webel R; Aggarwal K; Alpert MA
    Catheter Cardiovasc Interv; 2013 Feb; 81(2):223-31. PubMed ID: 22488783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of early invasive or initially conservative strategies in patients with non-ST-segment elevation acute coronary syndrome at intermediate or high risk].
    Nie SP; Ma CS; Lü Q; Zhang Y; Du X; Kang JP; Hao P; Liu T; Wang S; Dong JZ; Liu XH; Wu XS
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Apr; 33(4):307-11. PubMed ID: 15932657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early invasive versus selectively invasive strategy in patients with non-ST-segment elevation acute coronary syndrome: impact of age.
    Angeli F; Verdecchia P; Savonitto S; Morici N; De Servi S; Cavallini C
    Catheter Cardiovasc Interv; 2014 Apr; 83(5):686-701. PubMed ID: 24282083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diverging associations of an intended early invasive strategy compared with actual revascularization, and outcome in patients with non-ST-segment elevation acute coronary syndrome: the problem of treatment selection bias.
    Hirsch A; Windhausen F; Tijssen JG; Oude Ophuis AJ; van der Giessen WJ; van der Zee PM; Cornel JH; Verheugt FW; de Winter RJ;
    Eur Heart J; 2009 Mar; 30(6):645-54. PubMed ID: 18824461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic impact of chronic kidney disease on 10-year clinical outcomes among patients with acute coronary syndrome.
    Dohi T; Kasai T; Miyauchi K; Takasu K; Kajimoto K; Kubota N; Amano A; Daida H
    J Cardiol; 2012 Dec; 60(6):438-42. PubMed ID: 23063662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Culprit-only or multivessel percutaneous coronary stenting in patients with non-ST-segment elevation acute coronary syndromes: one-year follow-up.
    Zapata GO; Lasave LI; Kozak F; Damonte A; Meiriño A; Rossi M; Carbó S; Pollice A; Paolasso E; Picabea E
    J Interv Cardiol; 2009 Aug; 22(4):329-35. PubMed ID: 19515083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-year clinical outcomes in the ICTUS (Invasive versus Conservative Treatment in Unstable coronary Syndromes) trial a randomized comparison of an early invasive versus selective invasive management in patients with non-ST-segment elevation acute coronary syndrome.
    Damman P; Hirsch A; Windhausen F; Tijssen JG; de Winter RJ;
    J Am Coll Cardiol; 2010 Mar; 55(9):858-64. PubMed ID: 20045278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of contrast-induced acute kidney injury with long-term cardiovascular events in acute coronary syndrome patients with chronic kidney disease undergoing emergent percutaneous coronary intervention.
    Watabe H; Sato A; Hoshi T; Takeyasu N; Abe D; Akiyama D; Kakefuda Y; Nishina H; Noguchi Y; Aonuma K
    Int J Cardiol; 2014 Jun; 174(1):57-63. PubMed ID: 24726211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of chronic kidney disease on clinical outcomes in patients with non-ST elevation myocardial infarction receiving percutaneous coronary intervention - A five-year observational study.
    Wang HT; Chen YL; Wu CJ
    Int J Cardiol; 2016 Oct; 220():166-72. PubMed ID: 27379919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early or late intervention in high-risk non-ST-elevation acute coronary syndromes: results of the ELISA-3 trial.
    Badings EA; The SH; Dambrink JH; van Wijngaarden J; Tjeerdsma G; Rasoul S; Timmer JR; van der Wielen ML; Lok DJ; van 't Hof AW
    EuroIntervention; 2013 May; 9(1):54-61. PubMed ID: 23685295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of severity of renal dysfunction on determinants of in-hospital mortality among patients undergoing percutaneous coronary intervention.
    Parikh PB; Jeremias A; Naidu SS; Brener SJ; Lima F; Shlofmitz RA; Pappas T; Marzo KP; Gruberg L
    Catheter Cardiovasc Interv; 2012 Sep; 80(3):352-7. PubMed ID: 22566286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An invasive management strategy is associated with improved outcomes in high-risk acute coronary syndromes in patients with chronic kidney disease.
    Medi C; Chew DP; Amerena J; Coverdale S; Soman A; Astley C; Rankin J; Brieger D
    Intern Med J; 2011 Oct; 41(10):743-50. PubMed ID: 21040324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of upstream tirofiban versus downstream tirofiban on myocardial damage and 180-day clinical outcomes in high-risk acute coronary syndromes patients undergoing percutaneous coronary interventions.
    Liu T; Xie Y; Zhou YJ; Li YP; Ma HY; Guo YH; Liu YY; Zhao YX; Shi DM
    Chin Med J (Engl); 2009 Aug; 122(15):1732-7. PubMed ID: 19781316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of treatment in acute coronary syndromes in the elderly: impact on decision making and clinical outcome after interventional versus conservative treatment.
    Rittger H; Schnupp S; Sinha AM; Breithardt OA; Schmidt M; Zimmermann S; Mahnkopf C; Brachmann J; Rieber J
    Catheter Cardiovasc Interv; 2012 Nov; 80(5):735-43. PubMed ID: 22121113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic impact of types of atrial fibrillation in acute coronary syndromes.
    Lau DH; Huynh LT; Chew DP; Astley CM; Soman A; Sanders P
    Am J Cardiol; 2009 Nov; 104(10):1317-23. PubMed ID: 19892044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of use and effectiveness of early invasive strategy in non-ST-segment elevation acute coronary syndromes: an assessment by propensity score.
    Ferreira-González I; Permanyer-Miralda G; Heras M; Cuñat J; Civeira E; Arós F; Rodríguez JJ; Sánchez PL; Marsal JR; Ribera A; Marrugat J; Bueno H;
    Am Heart J; 2008 Nov; 156(5):946-53, 953.e2. PubMed ID: 19061711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of updated guidelines on short- and long-term mortality in patients with non-ST-segment elevation acute coronary syndrome (NSTE-ACS).
    Vogel B; Hahne S; Kozanli I; Kalla K; Jarai R; Freynhofer M; Smetana P; Nürnberg M; Geppert A; Unger G; Huber K
    Int J Cardiol; 2012 Sep; 159(3):198-204. PubMed ID: 21447430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of chronic total occlusion and chronic kidney disease in patients undergoing primary percutaneous coronary intervention for acute ST-elevation myocardial infarction.
    Bataille Y; Plourde G; Machaalany J; Abdelaal E; Déry JP; Larose E; Déry U; Noël B; Barbeau G; Roy L; Costerousse O; Bertrand OF
    Am J Cardiol; 2013 Jul; 112(2):194-9. PubMed ID: 23601580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.